28 April – At the prestigious Healthcare Asia Pharma Awards 2025 held in Malaysia, Cipla Emerging Markets and Europe business was honored with two distinguished awards, underscoring the company’s leadership in promoting environmental, social, and governance (ESG) initiatives. Cipla’s commitment to improving healthcare and making a positive impact on society was recognized through their impactful campaigns and initiatives.
The first accolade, the ESG Program of the Year- India, was awarded for the “Ahead and Apart” campaign. This initiative was designed to address critical healthcare challenges in India while promoting sustainable practices. The campaign focused on raising awareness about key health issues and leveraging innovative strategies to improve access to essential healthcare services. By integrating ESG principles into its operations, Cipla demonstrated its role in fostering positive societal changes and sustainability in the pharmaceutical industry.
The second award, Most Differentiated Service of the Year- India, was presented for Cipla’s “Breathefree Digital Educator” initiative. This program aimed to enhance the management of respiratory diseases in India, particularly asthma and chronic obstructive pulmonary disease (COPD). The Breathefree Digital Educator initiative focused on digital engagement, educating patients and healthcare professionals about the latest treatments, offering support, and providing educational content that empowers individuals to better manage their health.
These recognitions highlight Cipla’s ongoing efforts to integrate ESG strategies into its business operations and reaffirm its position as a responsible leader in the pharmaceutical sector. Cipla continues to innovate and drive change through its commitment to healthcare, sustainability, and social impact. By placing emphasis on environmental and social responsibility, Cipla is paving the way for future improvements in healthcare delivery and sustainability.
Source: Cipla Twitter
